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Abstract: The presence of satisfactory bone volume is fundamental for the achievement of osseoin-
tegration. This systematic review aims to analyse the use of titanium meshes in guided bone
regeneration in terms of bone gain, survival and success rates of implants, and percentages of ex-
posure. An electronic search was conducted Articles were selected from databases in MEDLINE
(PubMed), SCOPUS, Scielo, and Cochrane Library databases to identify studies in which bone regen-
eration was performed through particulate bone and the use of titanium meshes. Twenty-one studies
were included in the review. In total, 382 patients, 416 titanium meshes, and 709 implants were
evaluated. The average bone gain was 4.3 mm in horizontal width and 4.11 mm in vertical height.
The mesh exposure was highly prevalent (28%). The survival rate of 145 simultaneous implants
was 99.5%; the survival rate of 507 delayed implants was 99%. The success rate of 105 simultaneous
implants was 97%; the success rate of 285 delayed implants was 95.1%. The clinical studies currently
available in the literature have shown the predictability of this technique. It has a high risk of
soft tissue dehiscence and membrane exposure although the optimal management of membrane
exposition permits obtaining a sufficient bone regeneration volume and prevents compromising the
final treatment outcome.
Keywords: titanium mesh; bone graft; guided bone regeneration; ridge augmentation
1. Introduction
Satisfactory bone volume is the first condition for obtaining a predictable long-term
prognosis in oral implantology. However, some patients may present inadequate bone,
which frequently makes difficult the successful outcome of the correct implant placement.
Different techniques have been developed to increase bone volume, but at the present
time, guided bone regeneration (GBR) represents the gold standard in bone regeneration
for implant placement [1,2]. The biological bases of this technique focus on the “PASS”
principles: primary closure, angiogenesis, space maintenance, and blood clot stability [3],
in other words, this technique focus on the mechanical protection of the blood clot and the
isolating of the bone defect, by using a barrier, to facilitate the migration and proliferation
of bone-forming cells and to prevent soft tissue colonization inside the bone defect [1,4].
In the last two decades, several membrane designs have been studied. They can be
divided into two categories: absorbable and non-resorbable, with different physical and
biomaterial properties between them, but all types must have some properties such as
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biocompatibility, tissue integration, space-making, cell selectivity, tissue integration, and
clinical manageability [5,6]. The physical and biomaterial properties of the membranes
will influence the development of their function, as well as the result of the treatment,
therefore, it will be of great importance to know the advantages and disadvantages of each
of them [5,6].
The non-resorbable barriers are expanded and dense forms of titanium-reinforced
polytetrafluoroethylene membranes (e-PTFE and d-PTFE), the titanium foils, and perfo-
rated titanium meshes (preshaped or customized) (Figure 1).
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Figure 1. (a) Custom-made titanium mesh (AVINENT® Digital Health); (b) Use of Computer-Aided Design (CAD) and
Computer-Aided manufacturing (CAM)to design custom-made devices for guided bone regeneration (GBR).
The biggest disadvantage of these types of membranes is they ne d to be removed
with a second-stage surgical procedure. Despite this, they offer several advantages such
as, maintaining the space for a sufficient period of time, providing an effective bar ier
function in terms of biocompatibility, they are simple to manage and present a reduced
risk of long-term complications [7].
In cases where vertical augmentation is desired, or in the presence of severe bone
atrophy, the use f stable membranes is required. To satisfy th s
requirements, th e-PTFE membranes w re subjected to modifications such as titanium
reinforcement that favoured their properties a i ili , t se of screws in its
fixation to improve stability [8]. Thus, the titanium mesh appeared to intend to obtain a
balance betwe n the ideal malleability and enough rigidity to accomplish reconstructions
of wide bone defects [9].
In the last 8 years, only three reviews about this subject have been conducted [10–12],
therefore, the main objective was to assess the use of titanium meshes during guided bone
regeneration, the quantity of augmented bone, survival and success rates of implants,
complications, and predictability of this surgical technique.
2. Materials and Methods
The systematic review was reported following the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) scale [13]).
2.1. Focused Questions
The following focused questions were formulated:
1. Is the use of titanium mesh in combination with a particulate bone graft (autologous
and/or heterologous) a successful technique regarding the quantity of augmented bone?
2. What is the percentage of membrane exposures?
3. What are the implant survival, success, and failure rate when performing this bone
regeneration technique in simultaneous or delayed implant placement?
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2.2. PICO Question
Bulleted lists look like this:
• P: Patients with partially o total edentulism candidates for GBR.
• I: Bone regeneration through autologous and/or heterologous bone graft and the use
of titanium meshes.
• C: Different grafting materials and techniques.
• O: The success rate of this technique regarding the quantity of augmented bone,
complications, and predictability of this surgical technique.
2.3. Eligibility Criteria
Inclusion criteria: (i) Studies in which a bone regeneration was performed using
particulate bone graft (autologous and/or heterologous) and the use of titanium meshes;
(ii) Clinical trials, cohort studies, and case series; (iii) Published in English or Spanish; (iv)
Minimum 6 months follow-up period.
Exclusion criteria: (i) Studies performed in vitro or on animals; (ii) Systematic reviews,
case reports, and expert opinions; (iii) Studies published before January 2000.
2.4. Information Sources
An electronic search was conducted in MEDLINE (PubMed), SCOPUS, Scielo, and
Cochrane Library databases for articles published between 2000 and 2021. References of
relevant studies selected were also searched to identify articles with potential inclusion.
The last search was performed on 8th January 2021.
2.5. Search Strategy
The following search terms were used:
1. (Titanium mesh [All Fields] AND bone graft [All Fields]).
2. ((Titanium mesh [All Fields] AND (guided bone regeneration [All Fields] OR GBR
[All Fields])).
3. (Titanium mesh [All Fields] AND ridge augmentation [All Fields]).
2.6. Study Selection
All articles were reviewed initially by three experts (R.A.-A., E.R.-M., and B.G.-N.). In
the event of any discrepancies, these were resolved by J.L.-L.
The first phase of the research consisted of the selection of titles, to eliminate those not
concerning our research and eliminate the repeated ones. The second phase consisted of
reading the abstract of each article to evaluate some parameters of inclusion. Finally, the
full text of all studies selected was obtained.
2.7. Data Collection Process and Items
One reviewer R.A.-A., extracted the data from the selected studies, including character-
istics of the study (authors, year of publication, country, and design), sample characteristics
(number of patients, mean ages, and number of sites), surgery characteristics (the type
of defect, type of surgery performed and materials used) and finally, the post-operatory
details and outcomes (follow-up period, percentage of membrane exposures, horizon-
tal/vertical bone regeneration obtained and implant survival, success, and failure rate)
which were synthesized in Table 1 and Table 5. A second author (B.G.-N.) verified all the
information collected.
The implant success rate was evaluated according to Albrektsson et al. criteria [14]: (i)
Absence of subjective complaints such as pain, foreign body sensation, and/or dysesthesia;
(ii) Absence of mobility; (iii) Absence of peri-implant radiolucency and infection with pus
suppuration; (iv) Marginal bone resorption (MBR) not exceeding 1.5 mm after the first year
of loading and up to 0.2 mm yearly thereafter.
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2.8. Risk of Bias in Individual Studies
The methodology of the included randomized clinical trials (RCT) was evaluated
using the Cochrane Collaboration’s risk of bias (RoB 2) tool [15]. The risk of bias for the
non-randomized clinical trials (NRCT), was determined using the non-randomized clinical
trials of Interventions (ROBINS-I) assessment tool [16]. The risk of bias was classified as
“low risk”, “unclear risk”, and “high risk”.
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M F (y) Mx Md MHA MVA
Malik et al.,
2020/India [36] Case series 12 8 48.7 0 20 V TMAP 6 20 - 4.82
Cucchi et al.,
2020/Italy [37] Case series 5 5 52 5 5 V Autologous + ABB 50:50 6−9 10 - 4.5
Mx: Maxilla; Md: Mandible; MHA: Mean horizontal augmentation; MVA: Mean vertical augmentation C: Combined; H: Horizontal; V:
Vertical; S: Socket; DBBM: Demineralized bovine bone mineral; ABB: Inorganic bovine bone; BPBM: Bovine porous bone protein; TMAP:
Thermoplastic mouldable allograft paste. RCT: Randomized clinical trial; NRCT: Non-randomized clinical trial.1: Referred to vertical and
horizontal bone fill of sockets after tooth extraction; CD: Conventional device; CMD: Custom made device.
3. Results
3.1. Study Selection
A total of 572 articles were identified in the first phase of the research. During the
second phase, 94 articles were considered, and after full-text evaluation 16 studies were
included in the review. Finally, five articles of interest were obtained through manual
research obtaining a total of 21 articles were included in this review [17–37] (Figure 2).
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3.2. Study Methods and Characteristics
Four studies were RCT [20,24,33,35], 2 were NRCT [21,28], 2 were prospective stud-
ies [22,32] and 13 were case series [17–19,23,25–27,29–31,34,36,37] and all of them were
published between 2001 and 2021 (Table 1).
The studies were conducted in nine different countries, the total number of patients in-
cluded was 382 (137 males, 193 females, and 52 non-specified) and a total of 416 titanium meshes.
There were four articles in which the gender was not specified [20,33–35]. The study
with a higher number of patients was Miyamoto et al. (N = 41) [17] while the one with
fewer patients was Ciocca et al. [29] with a total of nine patients. The mean age was 53.4
and four articles did not specify the mean age [24,27,34,35].
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Regarding the characteristics of the surgeries performed, it was quantified the number of
sites, and whether if it was in mandible or maxilla. In five studies, the number of sites was not
specified [18,28,30,34,35], of which 164 sites belong to the maxilla and 129 to the mandible.
In 16 studies the graft material used was autologous bone; in six of them it was
the only material used [17,18,20,21,23,28] (N = 120), and in the other 10 articles, autol-
ogous bone was associated with other graft materials such as inorganic bovine bone
(ABB) [19,22,25,26,32,35,37] (N = 91), thermoplastic mouldable allograft paste (TMAP) [33]
(N = 28), bovine porous bone protein (BPBM) [21] (N = 3), demineralized bovine bone
mineral (DBBM) [27] (N = 13) or Hydroxyapatite [29] (N = 21). There were five studies in
which autologous bone was not used and the regeneration was performed only with the
use of ABB [24,30,34] (N = 67) or TMAP (36,31) (N = 39).
The removal of the mesh and the quantification of bone gains was performed during
the second-stage surgery or also called in most studies as healing period, which was
performed on average at 6.5 months.
3.3. Quality Assessment and Risk of Bias within Studies
The risk of bias of the RCT is presented in Table 2. Three RTCs were considered as
having a low risk of bias even though there were some concerns about the blinding of
participants and researchers [24,33,35] and Atef et al. did not report the blinding of outcome
assessment and selective outcome reporting, potentially introducing selection bias [35].
One study was considered as having a high risk of bias since there were some concerns
about the random sequence generation, the allocation concealment, and the blinding of
participants and researchers [20].
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(The systematic review was reported following the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) scale [13]) with 21 items.
3.4. Characteristics of the Mesh
Different types of meshes were used in the studies, all of them are summarized in Table 4.
Table 4. Characteristics of the meshes used.
Authors Characteristics of the Mesh Used Thickness
Miyamoto et al., 2001 [17] Preshaped titanium mesh (M-TAM, Stryker Leinger GmbH & Co.,KG, Freiburg ASTM F-67 Jeil Medical Corp., Seoul, Korea) 0.1 and 0.2 mm thick
Degidi et al., 2003 [18] Preshaped micromesh (Cortical Mesh, Micronova, Bologna, Italy) NE
Proussaefs et al., 2006 [19] Preshaped titanium mesh (Osteo-Tram; OsteoMed) 0.2 mm thick
Pinho et al., 2006 [20] Preshaped titanium mesh (Frios Boneshield; DENTSPLY Friadent) NE
Corinaldesi et al., 2007 [21] Preshaped and trimmed titanium micromesh (ACE surgical supply,Straumann) 0.2 mm thick
Pieri et al., 2008 [22] Preshaped titanium mesh (Modus 1.5 Mesh, Straumann,Waldenburg, Switzerland) NE
Corinaldesi et al., 2009 [23] Preshaped and trimmed titanium mesh (ACE Titanium Micro Mesh,ACE Surgical Supply Company; Modus 0.9 Mesh, Medartis) 0.2 mm thick
Torres et al., 2010 [24] Preshaped and trimmed titanium mesh NE
Her et al., 2012 [25] Preshaped and trimmed titanium mesh (Jeil Medical, Seoul,South Korea) 0.1 mm thick
Lizio et al., 2014 [26] Titanium mesh (ridge-form; OsteoMed) 0.2 mm thick
Poli et al., 2014 [27] Preshaped and trimmed titanium mesh (ridge-form; (KLS Martin,Tuttlingen, Germany) 0.2 mm thick
Sumida et al., 2014 [28] Custom-made titanium mesh (Ace Surgical SupplyCo., Inc.Brockton, MA, USA) 0.5 mm thick
Uehara et al., 2015 [29] Preshaped and trimmed microtitanium mesh (Striker-Leibinger,Freiburg, Germany) 0.1 mm thick
Zita et al., 2016 [30] Titanium mesh (i–Gen, MegaGen, Gyeongbuk, Republic of Korea) NE
Bassi et al., 2016 [31] Titanium foil (grade 4) 0.2 mm thick
Ciocca et al., 2018 [32] Custom-made titanium mesh (Electro Optical Systems,Munich, Germany) 0.1 mm
Cucchi et al., 2019 [33] Preshaped titaium mesh (Trinon Titanium; Karlsruhe, Germany) NE
Zhang et al., 2019 [34] L-Shaped titanium mesh; Preshaped and trimmed 0.2 mm thick
Atef et al., 2020 [35] Preshaped titanium mesh (Bioinnovation, Brazil) NE
Malik et al., 2020 [36] Preshaped and trimmed titanium mesh NE
Cucchi et al., 2020 [37] Custom-made titanium mesh (3D-Mesh





The bone gains were quantified using cone-beam computed tomography (CBCT) im-
ages. In two studies, width bone gain was quantified [30,35], five studies quantified height
bone gain [21,23,33,36,37], six studied both width and height bone gains [17,22,24,29,31,34]
and finally 5 works did not quantify any bone gains after the surgery [18,22,26,27,29]. The
average bone gains were 4.3 mm in horizontal width (range 3.1 mm performed with ABB to
8.6 mm performed with TMAP) and 4.11 mm in vertical height (range 2.56 mm performed
with autologous and ABB 50:50 to 8.9 mm performed only with autologous).
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One study performed GBR after tooth removal, to evaluate the prevention of alveolar
collapse after tooth extraction, using titanium membrane [20].
Four studies evaluated the histologic and histomorphometric outcomes of GBR from
biopsies of the newly regenerated bone [19,21,31,33]. According to Bassi et al. [31], the
histological and histomorphometric analysis of the samples demonstrates the effectiveness
of GBR employing titanium mesh, as a barrier membrane. Cucchi et al. [33] concluded that
the regenerated bone differed from the native bone in terms of trabecular organization, as
well as newly formed bone remained immature and very different from the native bone.
Proussaefs et al. [19] demonstrated 36.47% of bone formation when the titanium mesh was
used in combination with autogenous bone and ABB. Corinaldesi et al. [21] concluded
that BPBM (30%) in combination with the autologous bone (70%) yielded similar bone
formation patterns as autologous bone alone.
3.6. Mesh Exposure
Except for Corinaldesi et al. [21] all the included studies evaluated the mesh exposure
(N = 404), and it proved to be a highly prevalent complication, appearing in 115 cases out
of 404 meshes (28%) (range 0% to 80%). Of these 115 exposed meshes, 25 were removed
due to more severe complications, and 75 were stabilized and controlled through local
hygiene measures.
According to the studies in which the implant was placed simultaneously [18,23,30,33,34]
the mesh exposure rate was 14% (13 out of 87). In contrast, in the cases of guide bone
regeneration (GBR) and delayed implant placement [17,19,21–25,27,29,31,32,37] the mean
mesh exposure rate was 30% (58 out of 187).
3.7. Implant Placement
Apart from performing the alveolar ridge augmentation, there were 16 studies in
which dental implants were placed [18,19,21–25,27,29–34,37] (Table 4). The other five
studies focused on the bone regeneration process without involving implant placement.
The outcomes were studied and summarized in Table 5.
In total, 709 implants were placed and the total prevalence of implant failure in this
review was 0.5% (4 implants were lost). The follow-up time after the implant placement
was on average of 32 months (range 6 to 96).
In five studies, bone augmentation was performed simultaneously with implant place-
ment (N = 145) [18,23,30,33,34], in the other studies, the implant placement was delayed after
7,1 months on average (N = 564) (range 3 to 10 months) [17,19,21–25,27,29,31,32,37].
The implant success rate was assessed considering at least 6 months from the prosthetic
load. The survival rate of 145 simultaneous implants was 99.5%; the survival rate of
507 delayed implants was 99%. The success rate of 105 simultaneous implants was 97%;
the success rate of 285 delayed implants was 95.1%. Proussaefs et al. [19] did not specify
the survival and success rates and Corinaldesi et al. [21], Torres et al. [24], Zita et al. [30],
and Ciocca et al. [32] did not specify the success rate.
The marginal bone resorption (MBR) was evaluated in 6 studies and it was on average
of 0.75 mm [19,22–24,30,31,37] (N = 234). There were no statistically significant differences
between de MBR observed in the simultaneous implants and delayed implants.
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Torres et al., 2010/Spain [24] After 6 months 97 3 - - 98.6 24
Her et al., 2012/South Korea [25] After 5−7 months 27 41 0 - 100 100 6−24
Poli et al., 2014/Italy [27] After 6 months 16 4 0 1.74 M,1.91 D 100 100 88
Uehara et al., 2015/Germany [29] After 6 months 64 1 - - 98.4 40
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Zhang et al., 2019/China [34] Simultaneously 16 0 0 0.81 V0.13 H 93.75 100 24
Cucchi et al., 2020/Italy [37] After 6−9 months 14 12 0 0 MBR 100 100 12
M: Mesial; D: Distal; MBR: Marginal bone resorption; V: Vertical; H: Horizontal.
4. Discussion
From the analysis of the recent published articles, few studies concerning GBR using
titanium mesh were published. The present systematic review aimed to evaluate the
results reported in the literature evaluating the following aspects: (a) the success rate of
this technique regarding the quantity of augmented bone; (b) the complications rate by
means of exposure; (c) the implants survival and success rate. The topic was focused on the
presence of the titanium meshes used as a physical barrier for ridge reconstruction in partial
or total edentulism, preventing soft tissue colonization and allowing osteoprogenitor cells
to reach the site and form new bone.
4.1. Bone Gain
The use of non-resorbable titanium meshes allows maintaining the shape between
the barrier and the bone defect. Furthermore, the pores allow to maintain vascularization
both to the soft tissue and to the bone during the regeneration process and facilitates tissue
nutrition [12,38]. Generally, the literature showed that the use of non-resorbable titanium
meshes in GBR represent a safe and predictable technique to gain vertical and/or horizontal
bone augmentation, in the treatment of small and medium-sized defects around dental
implants and prevention of alveolar ridge after tooth extraction [9,20,30,35]. The analysis of
the studies included in the present systematic review corroborates this statement, although
only six included studies quantified both width and height bone gains [17,19,22,24,31,34].
The histological and histomorphometric analysis also demonstrates the effectiveness of
GBR using the titanium mesh, and good capacity of the method to increase bone volume
in the distal mandibular atrophies [19,21,31,33]. On the other hand, other authors like
Uehara et al. [29] appear more doubtful about the success of this technique. According to
their success criteria, only 13 sites were judged as successful with a success rate of 56.6%,
emphasizing that, the greatest success rate was obtained at the sites with a shorter span
of augmentation.
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When comparing the success of this technique with other GBR techniques such as the
use of PTFE membranes, results of bone gain did not differ much. Cucchi et al. [39] found
that the height bone gain was 4.2 (range 2.7 to 5.8) mm when using PTFE and 4.1 (range
2.6 to 6.3) mm when using a titanium mesh. Sagheb et al. [40], found a height bone gain
higher (4.16 and 5.5 mm).
Table 6. Incidence of membrane/barrier exposure in different techniques.
Author Type of Barrier/Membrane Exposure Rate (%)
Rasia dal Polo et al. [10] Titanium mesh 16
Ricci et al. [11] Titanium mesh 22
Briguglio et al. [12] Titanium mesh 52
Wessing et al. [41] Collagen membrane 20
Wessing et al. [41] Cross-linked membrane 28
Ricci et al. [11] d-PTFE 17
Roca-Millan et al. [42] Titanium foils 23
4.2. Mesh Exposure
From the analysis of the complications, the investigation was focused on mesh ex-
posures which was the most usual complication when performing this technique. To
prevent premature exposure of the augmented area, all the analysed studies highlighted
the necessity to mobilize the flaps to obtain a primary wound closure without tensions.
According to the results of this review, the mean rate of mesh exposure was 28%. Other
reviews about membrane/mesh exposure were found in the literature (Table 6).
The prevalence of mesh exposure in the cases of GBR and delayed implant placement
was higher than when simultaneous implant placement. The reason for this higher inci-
dence might be correlated with “free-end” edentulism and severe vertical ridge resorption,
as well as a low number of included cases in the simultaneous placement group.
Some authors propose that to reduce the rate of mesh exposure, consensus proto-
cols are needed, but also more precise customized meshes. Also, the use of resorbable
membranes and PRP to prevent the risk of early dehiscence [18,43,44].
Even though the most frequent complication associated with this device is its exposure,
according to the results of this review, it is worth noting that this event does not necessarily
compromise the final treatment outcome and further complications were avoided using
topical application of chlorhexidine gel [19,25].
Comparing to other types of techniques, Garcia et al. [45] found that when GBR
is associated with collagen membranes or e-PTFE, the exposure of the membrane may
influence bone gain. The sites without exposure achieved 74% more horizontal bone
gain than sites with membrane exposure. In all types of GBR, meticulous soft-tissue
handling is mandatory to obtain flaps without tension over the membranes, in order that
the regenerative tissue can be kept entirely covered. When a titanium mesh is exposed and
the grafted bone had been sufficiently stabilized by newly formed bone, the integrity of
the hole new bone regeneration can be mostly ensured and avoid superinfection. This is
possible due to its pores since they play a crucial role in vascularization of the graft and
allows its hygiene [19,23,25].
4.3. Characteristics of the Mesh
Regarding the thickness of the mesh most currently used is 0.2 mm (range 0.1–0.5 mm),
since it provides sufficient rigidity to maintain space and protect the graft [34,37]. According
to other authors, a titanium mesh should be sufficiently stiff to be able to resist the muscular
tensions and the pressure of the surgical flap, but at the same quite manageable to be
adapted to the bone defect [10–12,30,34,37].
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The external form should be as round as possible to avoid damaging he flap and the
surface as smooth as possible to avoid bacterial colonization or infection [10,12,37]. In most
of the articles, the authors specify the devices were polished and rounded before placed, to
avoid dehiscence and soft tissue ruptures.
4.4. Implant Success and Survival Rates
It has been reported that the survival rates of implants placed in regenerated bone
were similar to those described for implants placed into native bone [44,45]. The implant
survival rate of the included articles of this review was 99.25% and the implant success
rate was 93.35%, similar to other works available in the literature [46,47].
4.5. Limitations
It must be taken into account the heterogeneity in design, data collection methods,
and analyses performed across the included studies. Moreover, the lack of RTCs with a
large sample is observed. Most of the included articles were case series, and some of them
did not report the bone gain obtained.
Despite the differences regarding the surgical protocols (collagen membrane asso-
ciation, different timing of mesh removal, different graft materials) results were similar.
Therefore, it was not easy to identify the most successful surgical technique when a titanium
mesh is used.
Only four studies performed controlled randomization [20,24,33,35], and in one of
them, the implant timing, the follow-up, and survival/success implant rates were not
specified [20].
5. Conclusions
Based on the literature presented, it is possible to assess that the use of a titanium
mesh in combination with autologous and/or heterologous particulate grafts represent a
safe and predictable technique to increase vertical and/or horizontal bone volume in cases
of defects in partially edentulous patients, in the treatment of small and medium-sized
defects around dental implants and alveolar ridge preservation after tooth extraction.
However, the use of titanium meshes presented disadvantages related to the necessity
of the second-stage surgical procedure, with increased patient morbidity and rehabilitation
time. Furthermore, it has a high risk of soft tissue dehiscence and membrane exposure.
The membrane exposure rate of this technique reaches 28% of the cases. The optimal
management of membrane exposition permits obtaining a sufficient bone regeneration
volume and prevents compromising the final treatment outcome.
The implant survival and implant success values are similar to those described for
implants placed into the native bone and when performing other GBR techniques. No
significant differences were observed between the implant survival and implant success
rates between simultaneous and delayed implant placement.
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